Status:
UNKNOWN
Rapid Vaccination of Hard-To-Reach Populations
Lead Sponsor:
The New York Academy of Medicine
Conditions:
Influenza
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to develop and determine the effectiveness of a multi-level community participatory intervention designed to rapidly immunize hard-to-reach populations, including substanc...
Detailed Description
This study follows a quasi-experimental design involving a multilevel community participatory intervention that is designed to rapidly immunize hard-to-reach (HTR) populations in disadvantaged minorit...
Eligibility Criteria
Inclusion
- The possible participant pool for this project is the adult population (over the age of 18) of 8 circumscribed neighborhoods in East Harlem and South Bronx in NYC. These neighborhoods have a total population of approximately 24,000 people (based on the 2000 US Census) and we anticipate that up to 4,000 may be among the eligible hard-to-reach populations that are the target of this proposal. We will identify eligible populations through a brief survey instrument. During the intervention phase of this study, persons who are eligible to receive influenza vaccination will be offered influenza vaccination. Eligibility criteria for influenza vaccination are the eligibility criteria established by the Advisory Committee on Immunization Practices guidelines. These will be determined as part of the standard data collection instrument. Eligible persons include persons over the age of 65 and persons concurrent comorbidity including immunosuppression (HIV or active injection drug use), chronic pulmonary or cardiovascular disorder (including asthma), or chronic metabolic diseases (including diabetes mellitus, renal or hepatic dysfunction).
Exclusion
- Exclusion criteria include an allergy to vaccines, an allergy to eggs, inability to provide consent, currently under care of a physician and a plan to receive influenza vaccine in the near-future, or having already received the influenza vaccine during this year (CDC 1999).
Key Trial Info
Start Date :
February 1 2004
Trial Type :
INTERVENTIONAL
End Date :
October 1 2005
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT00155974
Start Date
February 1 2004
End Date
October 1 2005
Last Update
September 22 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Urban Epidemiologic Studies, The New York Academy of Medicine
New York, New York, United States, 10029